Filings Radar

SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.

AXON ENTERPRISE, INC. (AXON)

CIK 0001069183 3 material events

Insider activity (SEC Form 4)

Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.

Open-market · last 30 days: 0 buyers bought $0 3 sellers sold $20.7M
Open-market · last 90 days: 0 buyers bought $0 3 sellers sold $37.7M
InsiderRoleDateTransactionSharesValue
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 71 $36K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 410 $207K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 1104 $558K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 744 $377K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 749 $380K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 1774 $902K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 1319 $672K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 1348 $688K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 1251 $640K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 1033 $530K
SMITH PATRICK W CHIEF EXECUTIVE OFFICER, Director 2026-09-08 Open-market sell 10b5-1 197 $101K
Brooks Cameron CHIEF REVENUE OFFICER 2026-08-31 Tax withholding 735 $416K
Coughlin Elizabeth Reid Chief Human Officer 2026-08-31 Tax withholding 479 $272K
Fields Isaiah Chief Legal Officer 2026-08-31 Tax withholding 763 $432K
Isner Joshua PRESIDENT 2026-08-31 Open-market sell 10b5-1 347 $195K
Isner Joshua PRESIDENT 2026-08-31 Open-market sell 10b5-1 373 $210K
Isner Joshua PRESIDENT 2026-08-31 Open-market sell 10b5-1 359 $202K
Isner Joshua PRESIDENT 2026-08-31 Open-market sell 10b5-1 1232 $695K
Isner Joshua PRESIDENT 2026-08-31 Open-market sell 10b5-1 661 $374K
Isner Joshua PRESIDENT 2026-08-31 Open-market sell 10b5-1 188 $106K
Most recent 20 reported transactions. Open-market buys (P) and sells (S) are the deliberate ones; grants and option exercises are compensation. Not investment advice.

Risk Radar (year-over-year Risk Factors)

← All Risk Radar

Fiscal period ending 2025-12-31 versus 2024-12-31view filing on EDGAR →

Persistent and newly identified material weaknesses in revenue recognition and debt accounting, combined with escalating debt-service language explicitly flagging default risk and restrictive covenant constraints, signal a materially deteriorating control and solvency risk profile. The restatement of 2027 Notes liability classification compounds litigation and regulatory exposure, while expanded M&A, defense-contract, and export-control disclosures broaden the risk surface across multiple themes. Partial easing from convertible note retirement is real but insufficient to offset the breadth and severity of worsening across governance, debt structure, compliance, and operations.

11 company-specific · 3 eased/removed · 1 common-mode

Company-specific changes

Revised

Material weakness in revenue recognition persists unresolved into 2025. New material weakness in convertible debt identified and remediated, indicating ongoing control deficiencies.

Failure to maintain effective internal control over financial reporting may adversely affect our ability to report our financial condition and operating results in a timely and accurate manner, which…

Revised

Company disclosed a NEW restatement of 2027 Notes liability classification, escalating from prior-year single ASC 606 error to multiple accounting errors, increasing litigation and regulatory risk.

Our revision and our restatement of previously issued consolidated financial statements may adversely affect investor confidence and could result in regulatory actions and stockholder litigation. We…

New

New disclosure of government contract risk and potential defense program cancellations. Material exposure to FAR compliance costs and loss of major defense contracts.

Uncertainties with complex U.S. federal, state and local and foreign procureme nt laws and regulations of governments could cause us to incur costs, which could have a material adverse effect on our…

New

New disclosure of restrictive debt covenants limiting operational flexibility, asset sales, distributions, and M&A. Material covenant breach risk.

Our indebtedness contains restrictive covenants that could limit our operational flexibility and adversely affect the value of our common stock . Our revolving credit facility, and the indentures…

Revised

Substantially expanded M&A risk disclosure. New specific risks: AI/ML model inherited risks, IP infringement claims, export controls, minority investment governance limitations, government contract loss post-acquisition, supply chain/manufacturing scaling challenges.

Acquisitions of, or investments in, other products, technologies or businesses could disrupt our business, dilute shareholder value, or adversely affect our operating results. Our business strategy…

Revised

New disclosure of PRC entity list restrictions and export controls on weapons/defense articles creating supply chain disruption and cost risks.

Our international operations expose us to additional risks that could harm our business prospects, operating results and financial condition. We have significant international operations and plan to…

Revised

New disclosure of restrictive covenants limiting operational flexibility. Removal of convertible feature and dilution risks suggests shift to traditional debt with covenant constraints.

Risks Related to our Indebtedness • Fulfilling our debt obligations requires significant cash resources, which may exceed our available cash flow. • The 2027 Note Hedge and Warrant transactions…

Revised

Added mitigation measures (tooling ownership, inventory buffers) offset by escalated tariff/trade policy risks. Shift from proposed tariffs to actual implementation and unpredictability materially worsens exposure.

Unavailability of materials or higher costs could adversely affect our financial results. We depend on U.S. domestic and international suppliers for the delivery of components used in the assembly of…

Revised

Added explicit reference to acquired businesses' AI governance risks and expanded employee training risk. Strengthened language on third-party data rights concerns, escalating compliance and integration risks.

Uncertainty in the development, deployment, and use of AI in our products and services, as well as our business more broadly, could adversely affect our business and reputation. We offer systems and…

Revised

Language shifted from "may not have sufficient" to "may exceed available cash flow," and added explicit default risk language. Tone escalated regarding debt servicing ability.

Fulfilling our debt obligations requires significant cash resources, which may exceed our available cash flow. Our ability to meet our debt obligations, including making, scheduled principal and…

Revised

Warrants remain outstanding post-note extinguishment, creating unhedged dilution risk. New disclosure of partial unwinding and continued exposure materially worsens shareholder dilution risk.

The 2027 Note Hedge and Warrant transactions may impact the value of our common stock . In connection with the pricing of the 2027 Notes, we entered into 2027 Note Hedge transactions and Warrant…

Eased / removed

Removed

Removal of conditional conversion risk on convertible notes. Elimination of liquidity and working capital pressure from potential forced cash settlement or liability reclassification materially eases debt risk.

The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results. If the conditional conversion feature of the Notes is triggered…

Removed

Removal of convertible notes dilution risk indicates the Notes were retired or converted, materially reducing shareholder dilution and stock price pressure risks.

Conversion of the Notes may dilute the ownership interest of our shareholders or could depress the price of our common stock. The conversion of some or all of the Notes could dilute our…

Removed

Removal of key-person risk disclosure for founder/CEO Patrick Smith. Material if reflects actual succession planning or reduced dependency; cosmetic if merely de-emphasized.

We depend on the services of our executive officers, including Patrick W. Smith, our Chief Executive Officer. Our failure to retain executive officers could adversely impact our business. Our future…

Also disclosed — common-mode (AI regulatory compliance)
AI regulatory compliance Revised

New disclosure of procurement law risks with explicit material adverse effect language suggests newly identified or escalated compliance exposure.

Legal and Compliance Risks • We may face personal injury, wrongful death, product liability and other liability claims that could harm our reputation and adversely affect our business prospects…

Material year-over-year changes to this company's Risk Factors (Item 1A), found by comparing each annual report to the prior year, judged for materiality, and classified as company-specific or common-mode against the cross-company catalog. Common-mode changes are the macro themes many companies disclose in common; they are collapsed above. A filing marked unchanged had no material change from the prior year; its summary describes the company's standing risks, which remain in force. Fiscal periods are the reporting period ends. Not investment advice.

Earnings release

8-K filed 2026-08-05 confidence 98% Item 2.02

Axon Enterprise issued a shareholder letter on August 5, 2026 disclosing Q2 2026 financial results including revenue of $904 million (up 35% YoY), net income of $29 million, and Adjusted EBITDA of $242 million, along with forward guidance raising full-year revenue growth outlook to 32-34%. This is a standard earnings release disclosure under Item 2.02 with detailed financial metrics and operational performance.

View raw filing on EDGAR →

Exec appointment

8-K filed 2026-07-10 confidence 92% Item 5.02

The filing discloses the appointment of two independent directors, Vivek Mohindra and Eiso Kant, to the Board of Directors of Axon Enterprise effective July 8, 2026, along with their committee assignments. While the disclosure also includes compensatory arrangements (RSU awards and cash retainers), the principal disclosed action centers on the appointment of these individuals to the Board and their committee roles, making exec_appointment the most salient classification. The material nature is clear given the addition of senior leadership to the Board.

View raw filing on EDGAR →

Shareholder vote

8-K filed 2026-06-01 confidence 98% Item 5.07

This is a clear disclosure of shareholder vote results from Axon Enterprise's 2026 Annual Meeting of Shareholders held on May 28, 2026. The filing reports voting outcomes for three proposals: election of nine directors, advisory approval of named executive officer compensation ("Say-on-Pay"), and ratification of PricewaterhouseCoopers LLP as independent auditor. The detailed vote tallies (FOR, AGAINST, WITHHELD/ABSTAIN, and broker non-votes) for each matter are the hallmark of Item 5.07 disclosures and are material to investors assessing board composition and governance.

View raw filing on EDGAR →